Binding of more than one Tva800 molecule is required for ASLV-A entry.

Understanding the mechanism by which viruses enter their target cell is an essential part of understanding their infectious cycle. Previous studies have focussed on the multiplicity of viral envelope proteins that need to bind to their cognate receptor to initiate entry. Avian sarcoma and leukosis virus Envelope protein (ASLV Env) mediates entry via a receptor, Tva, which can be attached to the cell surface either by a phospholipid anchor (Tva800) or a transmembrane domain (Tva950). In these studies, we have now investigated the number of target receptors necessary for entry of ASLV Env-pseudotyped virions.
Using titration and modelling experiments we provide evidence that binding of more than one receptor, probably two, is needed for entry of virions via Tva800. However, binding of just one Tva950 receptor is sufficient for successful entry.
The different modes of attachment of Tva800 and Tva950 to the cell membrane have important implications for the utilisation of these proteins as receptors for viral binding and/or uptake.
AuthorsEleanor R Gray, Christopher J R Illingworth, John M Coffin, Jonathan P Stoye
JournalRetrovirology (Retrovirology) Vol. 8 Pg. 96 ( 2011) ISSN: 1742-4690 [Electronic] England
PMID22099981 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Avian Proteins
  • Receptors, Virus
  • Tva receptor
  • Viral Envelope Proteins
  • Alpharetrovirus (physiology)
  • Animals
  • Avian Proteins (metabolism)
  • Cell Line
  • Cell Membrane (metabolism)
  • HEK293 Cells
  • Humans
  • Mice
  • Models, Biological
  • Receptors, Virus (metabolism)
  • Viral Envelope Proteins (metabolism)
  • Virus Attachment
  • Virus Internalization

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: